BCDA Biocardia Inc

USD 3.25 0.00 0
Icon

Biocardia Inc (BCDA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 3.25

0.00 (0.00)%

USD 5.93M

0.03M

N/A

N/A

Icon

BCDA

Biocardia Inc (USD)
COMMON STOCK | NSD
USD 3.25
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 5.93M

N/A

USD 3.25

Biocardia Inc (BCDA) Stock Forecast

N/A

Based on the Biocardia Inc stock forecast from 0 analysts, the average analyst target price for Biocardia Inc is not available over the next 12 months. Biocardia Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biocardia Inc is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Biocardia Inc’s stock price was USD 3.25. Biocardia Inc’s stock price has changed by +9.42% over the past week, -10.96% over the past month and -91.37% over the last year.

No recent analyst target price found for Biocardia Inc
No recent average analyst rating found for Biocardia Inc

Company Overview Biocardia Inc

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. Its lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clin...Read More

https://www.biocardia.com

320 Soquel Way, Sunnyvale, CA, United States, 94085

16

December

USD

USA

Adjusted Closing Price for Biocardia Inc (BCDA)

Loading...

Unadjusted Closing Price for Biocardia Inc (BCDA)

Loading...

Share Trading Volume for Biocardia Inc Shares

Loading...

Compare Performance of Biocardia Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BCDA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biocardia Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing BCDA

Symbol Name BCDA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biocardia Inc (BCDA) Stock

Stock Target Advisor's fundamental analysis for Biocardia Inc's stock is Bearish.

Unfortunately we do not have enough data on BCDA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BCDA's stock to indicate what its average analyst target is.

BCDA stock's Price/Earning ratio is 0.70. Our analysis grades BCDA stock's Price / Earning ratio at C. This means that BCDA stock's Price/Earning ratio is above 27% of the stocks in the Biotechnology sector in the NSD exchange. Based on this BCDA may be undervalued for its sector.

The last closing price of BCDA's stock was USD 3.25.

The most recent market capitalization for BCDA is USD 5.93M.

Unfortunately we do not have enough analyst data on BCDA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Biocardia Inc's stock.

As per our most recent records Biocardia Inc has 16 Employees.

Biocardia Inc's registered address is 320 Soquel Way, Sunnyvale, CA, United States, 94085. You can get more information about it from Biocardia Inc's website at https://www.biocardia.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...